Significance of Double blind
Double blind, across Ayurveda, Science, Psychiatry, and Health Sciences, consistently refers to a study design. It is a method where neither the participants nor the researchers are aware of who is receiving the actual treatment or a placebo. This approach aims to minimize bias and ensure objective results by preventing either the participants or the researchers from influencing the outcome based on their knowledge of the treatment assignments. This design is frequently used in clinical trials.
Synonyms: Double-blind study, Double-blind trial, Double-blind experiment, Placebo-controlled, Objective measurement, Randomized, Anonymous, Unbiased, Concealed, Hidden
The below excerpts are indicatory and do represent direct quotations or translations. It is your responsibility to fact check each reference.
Hindu concept of 'Double blind'
In Hinduism, "Double blind" refers to a research method. It's a study design where neither participants nor researchers know who receives the treatment or placebo. This minimizes bias, ensuring objective and reliable results.
From: Journal of Ayurveda and Integrated Medical Sciences
(1) Double blind refers to a study design where neither the participants nor the researchers know who is receiving the treatment, helping to reduce bias in the evaluation of Vedistry Arjuna + Tablet.[1] (2) A double blind study is a type of clinical trial where neither the participants nor the researchers know which treatment each participant is receiving, minimizing bias in the assessment of outcomes.[2] (3) A study design where neither the participants nor the researchers know who is receiving the active treatment or the placebo, ensuring objective results.[3] (4) This is a type of study design where neither the participants nor the researchers know who is receiving which treatment, to prevent bias and reduce the source of error.[4] (5) This describes a research method where neither the participants nor the researchers know who is receiving the actual treatment or a placebo.[5]
From: Journal of Ayurvedic and Herbal Medicine
(1) This phrase describes the type of study, and the diuretic effects of four traditional Vietnamese herbal remedies were tested under standardized conditions in a placebo controlled double blind crossover model.[6] (2) This is a study design where neither the participants nor the researchers know who is receiving the treatment or the placebo, to minimize bias in the evaluation of the drug's efficacy, as mentioned in the title.[7] (3) This term is used to describe a type of clinical trial where neither the participants nor the researchers know who is receiving the treatment.[8]
The concept of Double blind in scientific sources
Double-blind refers to a study design where neither participants nor researchers know the treatment assignments. This method, implemented in various research areas, aims to minimize bias by ensuring objectivity in results. It's used in trials, including those involving medication, and is crucial for unbiased findings.
From: International Journal of Pharmacology
(1) Double-blind studies are those where neither the participants nor the researchers know who is receiving a particular treatment, often used in trials of oral bacteriotherapy for chronic pouchitis.[9] (2) is a study design where neither the participants nor the researchers know who is receiving the active treatment (ELEJ) and who is receiving the placebo.[10] (3) Double blind, as used in the study, is a procedure where neither the participants nor the researchers know who is receiving a particular treatment, which helps to prevent bias in the results.[11]
From: Asian Journal of Pharmaceutics
(1) A study in which neither the participants nor the researchers know who is receiving a particular treatment.[12] (2) The physician who injected the drug and the patient was blinded on the type of medication administered, and the drugs were prepared by someone else.[13] (3) A randomized clinical trial method used in the study, where participants were assigned into intervention and control groups, receiving either E. amoenum extract or fluoxetine capsules.[14]
From: South African Family Practice
(1) A study design in which neither the participants nor the researchers know who is receiving the active treatment or the placebo, reducing bias in the assessment of treatment effects.[15] (2) This refers to a study design where neither the participants nor the researchers know who is receiving the active treatment or the placebo, to minimize bias in the results.[16] (3) This type of blinding means that neither the subjects nor the investigators know the group allocation, which can reduce bias.[17]
From: Journal of Public Health in Africa
(1) A randomized controlled trial was conducted from December 2017 to November 2018, where research participants were blinded to the allocation of participants to study groups.[18] (2) This is a study design where neither the participants nor the researchers know who is receiving the intervention.[19]
From: African Journal of Primary Health Care and Family Medicine
(1) A research method where neither the participants nor the researchers know who is receiving the active treatment and who is receiving a placebo, preventing bias.[20]
From: International Journal of Environmental Research and Public Health (MDPI)
(1) A double-blind study design ensures that neither the participants nor the researchers know who is receiving the active treatment or placebo, minimizing bias in research.[21] (2) A double-blind study is one where neither the participants nor the researchers know who is receiving the active treatment and who is receiving the placebo, minimizing bias.[22] (3) The Double-Blind nature of the study ensures that neither the patients, caregivers, investigators, nor research assistants knew which treatment, metformin or placebo, each participant was receiving until the trial was completed or terminated early.[23]
From: Sustainability Journal (MDPI)
(1) A study characteristic where both the individuals administering the training and the participants themselves were unaware of the specific assignment, minimizing expectancy effects on the results.[24]
From: International Journal of Pharmacology
(1) A method of blinding for implementers and participants, assessed as part of bias risk evaluation in breast cancer research.[25] (2) Neither the participants nor the researchers administering the treatments knew which drug was being given, reducing bias.[26] (3) Double-blind indicates that neither the participants nor the researchers know which treatment is being administered, preventing bias in the study.[27]
From: South African Journal of Psychiatry
(1) A type of trial of eicosapentaenoic acid (EPA) as supplemental treatment in patients with schizophrenia.[28] (2) Less than 10% of studies for the range of disorders in psychiatry for which second-generation antipsychotics have been tested are described by this term.[29]